// App-Quantinova.ai

Su1400 : Multimodality Therapy is Associated with Improved Cause-Specific Survival in Pancreatic Ductal Adenocarcinoma with Vascular Abutment

Researchers

Presenter

  • Mark S. Talamonti

Principal Investigators

  • Waseem Lutfi

  • Kristine M. Kuchta

  • David J. Winchester

  • Richard A. Prinz

  • Marshall Baker

Medical Centers

  • Surgery, University Chicago, Chicago, Illinois, United States

  • NorthShore University Health System, Evanston, Illinois, United States

  • Center for Biomedical Research Informatics, NorthShore University HealthSystem, Evanston, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Sepsis

  • Venous thrombosis

  • Microphthalmia, syndromic, 9

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • pharmacodynamics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved